Dr. Ballentine Carter Elected Trustee of the American Board of Urology
March 29, 2012 -- Dr. Ballentine Carter, a Prostate Cancer Foundation (PCF) funded researcher, mentor and sterling clinician, was elected Trustee of the American Board of Urology (ABU), beginning his six-year term on February 28, 2012. Dr. Carter is a Professor of Urology and Oncology and Director of Adult Urology at the James Buchanan Brady Urological Institute at Johns Hopkins School of Medicine. PCF is currently funding the expansion of Dr. Carter’s National Proactive Surveillance Network through a $5 million grant.
The National Proactive Surveillance Network for prostate cancer was established by Dr. Carter in 1995 and has since become one of the largest and longest running longitudinal studies of its kind. The Network will go live online this year.
“In addition to Dr. Carter’s specialization in the management of prostate disease with a focus on prostate cancer, he has consistently made scholarly contributions that have changed the practice of urology,” said Dr. Jonathan Simons, President and CEO of the Prostate Cancer Foundation. “In fact, Dr. Carter has written more than 180 scholarly papers in the field of prostate cancer and performed more than 2,800 radical prostatectomies—and undoubtedly—helped millions of men affected by prostate cancer.
Founded in 1935, the American Board of Urology acts for the benefit of the public to insure high quality, safe, efficient, and ethical practice of Urology by establishing and maintaining standards of certification for urologists. For more information on the ABU, please visit www.abu.org.